Tuesday, 25 June 2024

 

 

LATEST NEWS Punjab Government Sanctions Rs 34 Crore to 6786 Beneficiaries under Ashirwad Scheme : Dr. Baljit Kaur ADGP Law and Order, other officials brief MRT teams ahead of Amarnath Yatra Vigilance Bureau arrests Patwari taking Rs 5,500 bribe for mutation of land CET examination- CM ensures Job Security for Group C and Group D appointees Dr. Jitendra Singh Advocates for 'Indian Solutions for Indian Problems' at 6th National Convention of Vigyan Bharati Amit Shah chairs a high-level meeting to review the preparedness of flood management in New Delhi today Big jolt to Congress and BJP in Jalandhar! Many leaders of both parties joined 'AAP' Exim bank gives presentation to CM Sukhvinder Singh Sukhu on possible export strategy in Himachal CM Bhagwant Mann has demoralised Punjab Police CM Sukhvinder Singh Sukhu urges Finance Commission to recommend liberal financial assistance to Himachal Pradesh Chief Minister Nayab Singh, his Cabinet and MLAs visits Shri Ram Mandir in Ayodhya Eddie Guerrero Net Worth 2024 | Know Interesting Facts About Eddie PSPCL gives Green Energy a push Dave Bautista Net Worth 2024 | Know The Bautista’s Bio, Career, and Lifestyle Ric Flair Net Worth 2024 | The Nature Boy's income, Bio, Career, and Lavish Lifestyle LPU organises SUTAKS to explore Societal Impact of Technological Advancements Dadasiba hospital to be upgraded to a 100-bed facility : CM Sukhvinder Singh Sukhu MP Sanjeev Arora seeks rationalization of income tax rates for individuals in coming Budget from FM Nirmala Sitharaman Surjeet Slathia Inaugurates Volleyball Tournament, Advocates Youth Involvement in Sports Transformed J&K post Art 370 repeal best tribute to Syama Prasad Mukherjee : Devender Singh Rana NDA Members in a meeting in Bari Brahmana

 

Covid mRNA vaccines safe in patients with heart failure: Study

Omicron Variant, Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Liquid Medical Oxygen, Oximeter
Listen to this article

Web Admin

Web Admin

5 Dariya News

Copenhagen , 22 Aug 2022

Covid mRNA vaccines are associated with a decreased risk of death in patients with heart failure, says a new study.The study, presented at ESC Congress 2022, found that the vaccines were not associated with an increased risk of worsening heart failure, venous thromboembolism or myocarditis in heart failure patients.

"Our results indicate that heart failure patients should be prioritised for Covid-19 vaccinations and boosters," said study author Caroline Sindet-Pedersen of Herlev and Gentofe Hospital, Hellerup, Denmark.For the study, the team included 50,893 unvaccinated patients with heart failure in 2019 and 50,893 patients with heart failure in 2021 who were vaccinated with either of the two mRNA vaccines (BNT162B2 or mRNA-1273).

The two groups were matched for age, sex, and duration of heart failure. The median age of participants was 74 years and 35 per cent were women and the median duration of heart failure was 4.1 years.Participants were followed for 90 days for all-cause mortality, worsening heart failure, venous thromboembolism, and myocarditis, starting from the date of the second vaccination for the 2021 group and the same date in 2019 for the unvaccinated group.

The researchers compared the risk of adverse outcomes in the two groups, after standardising for age, sex, heart failure duration, use of heart failure medications, ischaemic heart disease, cancer, diabetes, atrial fibrillation, and admission with heart failure less than 90 days before the first date of follow up.

Among 101,786 heart failure patients, the researchers found that receiving an mRNA vaccine was not associated with an increased risk of worsening heart failure, myocarditis or venous thromboembolism but was associated with a decreased risk of all-cause mortality.

The standardised risk of all-cause mortality within 90 days was 2.2 per cent in the 2021 cohort (vaccinated) and 2.6 per cent in the 2019 cohort (not vaccinated), showing a significantly lower risk for all-cause mortality in 2021 versus 2019.

 

Tags: Omicron Variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Liquid Medical Oxygen , Oximeter

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2024 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD